マーケットレポート詳細
近赤外イメージングの世界市場：2028年に至る製品別、治療領域別予測
Near-infrared Imaging Market by Product (Imaging System, Probe, Dye (Organic, Nanoparticle)), Procedure (Cancer, CVD, GI, OB/GYN), Application (Preclinical, Clinical, Medical), End User (Hospital, Pharma, Research Lab) & Region - Global Forecast to 2028
- 出版元：MarketsandMarkets
出版元について - 発行年：2023年6月
- 定価 ：Single User License(1名様ライセンス)US$4,950(米国ドル)/ Multi User License(5名様)$6,650 / Corporate User License $8,150
- ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
- ご請求は円換算（お見積り日TTSレート）となります。
- 納品形態：PDF by Email
- 当調査レポートは英文233ページになります。
- 商品コード：MAM3302
お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。
【レポート紹介】
近赤外イメージングの世界市場規模は2023年で10億ドル、2028年に19億ドル、市場の平均年成長率は14.0%になると見込まれています。
レポートは近赤外イメージングの世界市場について2028年までの市場予測データ(金額US$)を掲載しています。同市場をさまざまな区分で細分化し、そのセグメント市場ごとの市場予測（製品別市場、治療別市場、等）を中心に構成されています。また競合状況、主要企業情報（20社）、業界構造分析、プライシング分析などの分析も加味し、近赤外イメージング市場の動向および今後成長性を詳細にレポートしています。
【レポート構成概要】
◆近赤外イメージングの世界市場予測2021-2028年
・市場規模(US$)
◆製品別、市場-2028年
デバイス
・蛍光イメージングシステム
・蛍光/生物発光イメージングシステム
近赤外イメージング剤/プローブ
・インドシアニングリーン
・その他試薬
近赤外染料
・有機染料
・ナノ粒子染料
※(市場規模US$)
◆治療別、市場-2028年
がん手術
・脳腫瘍/腫瘍外科
・その他がん手術
消化器外科
・結腸直腸手術
・その他消化器外科
心血管疾患
形成外科/再建手術
産婦人科手術
その他治療
※(市場規模US$)
◆用途別、市場-2028年
・前臨床イメージング
・臨床イメージング
・医用イメージング
※(市場規模US$)
◆エンドユーザー別、市場-2028年
・病院/外科クリニック
・医薬品/バイオテクノロジー企業
・研究ラボラトリ/学術機関
・その他エンドユーザー
※(市場規模US$)
◆主要国地域別市場-2028年
北米
・米国、カナダ
欧州
・ドイツ、フランス、英国
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・オーストラリア、韓国
・その他アジア太平洋
中南米
・ブラジル、メキシコ
・その他中南米
中東アフリカ
※地域別に全セグメントの細分化データ掲載、詳細は目次参照
※国別に製品別の細分化データ掲載、詳細は目次参照
◆市場分析
・市場ダイナミクス（促進要因、障壁、機会、課題）
・業界構造分析
・サプライチェーン分析
・特許分析
・貿易分析
・技術分析
・ケーススタディ分析
・プライシング分析
・競合状況
・市場シェア分析
◆近赤外イメージングの主要企業プロフィール動向
・STRYKER
・KARL STORZ SE & CO KG
・CARL ZEISS MEDITEC AG
・LEICA MICROSYSTEMS
・オリンパス株式会社
・株式会社 島津製作所
・PERKINELMER, INC
・LI-COR, INC
・浜松ホトニクス
・QUEST MEDICAL IMAGING BV
・SIGMA-ALDRICH (MERCK)
・ミズホ株式会社
・TELEDYNE PRINCETON INSTRUMENTS
・THERMO FISHER SCIENTIFIC INC
・FLUOPTICS
・MEDTRONIC
・CAYMAN CHEMICAL
・MP BIOMEDICALS
・CRYSTA-LYN CHEMICAL COMPANY
・GOWERLABS LTD
その他企業
・NIRX MEDICAL TECHNOLOGIES, LLC
・XENICS NV
・BIOTIUM
・TOKYO CHEMICAL INDUSTRY (INDIA) PVT LTD
・AAT BIOQUEST, INC
【レポート詳細目次、データ項目一覧は当ページ下を参照ください】
Table of Contents (英文詳細目次）
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKETS COVERED
1.3.1 MARKET SEGMENTATION
1.3.2 REGIONAL SEGMENTATION
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
1.6 RESEARCH LIMITATIONS
1.7 STAKEHOLDERS
1.8 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
・ FIGURE 1 NEAR INFRARED IMAGING MARKET: RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.2 PRIMARY RESEARCH 30
2.1.2.1 PRIMARY SOURCES
2.1.2.2 KEY INDUSTRY INSIGHTS
2.1.2.3 BREAKDOWN OF PRIMARIES
・ FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY AND DEMAND SIDE PARTICIPANTS
・ FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
・ FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH
・ FIGURE 5 APPROACH 1: MARKET SIZE ESTIMATION (COMPANY REVENUE ESTIMATION)
・ FIGURE 6 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF STRYKER
2.2.1.2 APPROACH 2: CUSTOMER-BASED MARKET ESTIMATION
・ FIGURE 7 NEAR-INFRARED IMAGING MARKET: BOTTOM-UP APPROACH
2.2.1.3 CAGR PROJECTIONS
・ FIGURE 8 CAGR PROJECTION: SUPPLY SIDE ANALYSIS
2.3 DATA TRIANGULATION
・ FIGURE 9 DATA TRIANGULATION METHODOLOGY
2.4 MARKET SHARE ASSESSMENT
2.5 STUDY ASSUMPTIONS
2.6 RISK ASSESSMENT
2.6.1 NEAR-INFRARED IMAGING MARKET: RISK ASSESSMENT
2.7 GROWTH RATE ASSUMPTIONS
2.8 NEAR-INFRARED IMAGING MARKET: RECESSION IMPACT
3 EXECUTIVE SUMMARY
・ FIGURE 10 NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
・ FIGURE 11 NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
・ FIGURE 12 NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2023 VS. 2028 (USD MILLION)
・ FIGURE 13 NEAR-INFRARED IMAGING MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
・ FIGURE 14 GEOGRAPHICAL SNAPSHOT: NEAR-INFRARED IMAGING MARKET
4 PREMIUM INSIGHTS
4.1 NEAR-INFRARED IMAGING MARKET OVERVIEW
・ FIGURE 15 RISING PREVALENCE OF TARGET DISEASES TO DRIVE MARKET
4.2 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT (2023 VS. 2028)
・ FIGURE 16 DEVICES SEGMENT TO DOMINATE NORTH AMERICAN NEAR-INFRARED IMAGING MARKET DURING FORECAST PERIOD
4.3 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY END USER (2023 VS. 2028)
・ FIGURE 17 HOSPITALS & SURGICAL CLINICS TO FORM LARGEST END USER SEGMENT IN ASIA PACIFIC MARKET
4.4 GLOBAL: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE (2023 VS. 2028)
・ FIGURE 18 FLUORESCENCE IMAGING SYSTEMS SEGMENT TO HOLD LARGEST SHARE DURING STUDY PERIOD
4.5 GEOGRAPHICAL SNAPSHOT OF NEAR-INFRARED IMAGING MARKET
・ FIGURE 19 CHINA TO WITNESS HIGHEST GROWTH RATE DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
・ FIGURE 20 NEAR-INFRARED IMAGING MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 INCREASING NUMBER OF SURGICAL PROCEDURES GLOBALLY
5.2.1.2 ADVANTAGES OF NEAR-INFRARED IMAGING OVER CONVENTIONAL VISUALIZATION METHODS
・ TABLE 1 ADVANTAGES OF NEAR-INFRARED IMAGING OVER CONVENTIONAL VISUALIZATION METHODS
5.2.1.3 TECHNOLOGICAL ADVANCEMENTS IN NEAR-INFRARED IMAGING MODALITIES
5.2.1.4 ADOPTION OF HYBRID NEAR-INFRARED IMAGING MODALITIES FOR SURGICAL GUIDANCE AND MOLECULAR IMAGING
5.2.2 RESTRAINTS
5.2.2.1 LENGTHY APPROVAL PROCESS OF NEAR-INFRARED FLUOROPHORES
5.2.2.2 HIGH INITIAL CAPITAL AND OPERATIONAL COSTS OF NEAR-INFRARED SYSTEMS 52
5.2.2.3 AVAILABILITY OF ALTERNATE TECHNOLOGIES
5.2.3 OPPORTUNITIES
5.2.3.1 GROWTH POTENTIAL FOR MAJOR PLAYERS IN EMERGING ECONOMIES
5.2.3.2 USE OF BLOCKCHAIN FOR DISTRIBUTION AND STORAGE OF MEDICAL IMAGES
5.2.4 CHALLENGES
5.2.4.1 HOSPITAL BUDGET CUTS
5.2.4.2 DEARTH OF TRAINED PROFESSIONALS IN EMERGING ECONOMIES
5.3 PORTER’S FIVE FORCES ANALYSIS
・ TABLE 2 NEAR-INFRARED IMAGING MARKET: PORTER’S FIVE FORCES ANALYSIS
5.3.1 THREAT OF NEW ENTRANTS
5.3.2 THREAT OF SUBSTITUTES
5.3.3 BARGAINING POWER OF SUPPLIERS
5.3.4 BARGAINING POWER OF BUYERS
5.3.5 INTENSITY OF COMPETITIVE RIVALRY
5.4 REGULATORY ANALYSIS
5.4.1 NORTH AMERICA
5.4.1.1 US
・ TABLE 3 US: APPROVED IMAGING DEVICES BY FDA
・ TABLE 4 US FDA: MEDICAL DEVICE CLASSIFICATION
・ TABLE 5 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.4.1.2 CANADA
・ TABLE 6 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
5.4.2 EUROPE
5.4.3 ASIA PACIFIC
5.4.3.1 JAPAN
・ TABLE 7 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA
5.4.3.2 CHINA
・ TABLE 8 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.4.3.3 INDIA
5.5 REIMBURSEMENT SCENARIO ANALYSIS
・ TABLE 9 MEDICAL REIMBURSEMENT CPT CODES FOR NEAR-INFRARED PROCEDURES IN US (AS OF 2021)
5.6 ECOSYSTEM MAPPING
5.7 VALUE CHAIN ANALYSIS
5.7.1 RESEARCH & PRODUCT DEVELOPMENT
5.7.2 RAW MATERIAL AND MANUFACTURING
5.7.3 MARKETING & SALES, SHIPMENT, AND POST-SALES SERVICES
・ FIGURE 21 VALUE CHAIN ANALYSIS—MAXIMUM VALUE ADDED DURING MANUFACTURING PHASE
5.8 SUPPLY CHAIN ANALYSIS
5.8.1 PROMINENT COMPANIES
5.8.2 SMALL & MEDIUM-SIZED ENTERPRISES
5.8.3 END USERS
・ TABLE 10 SUPPLY CHAIN ECOSYSTEM OF NEAR-INFRARED IMAGING MARKET
・ FIGURE 22 NEAR-INFRARED IMAGING MARKET: SUPPLY CHAIN ANALYSIS
5.9 PATENT ANALYSIS
・ FIGURE 23 PATENT DETAILS FOR NEAR-INFRARED IMAGING (JANUARY 2013–MAY 2023)
・ FIGURE 24 PATENT DETAILS FOR NEAR-INFRARED FLUORESCENCE IMAGING SYSTEMS (JANUARY 2013–MAY 2023)
・ FIGURE 25 PATENT DETAILS FOR NEAR-INFRARED DYES (JANUARY 2013–MAY 2023)
5.10 TRADE ANALYSIS
5.10.1 TRADE ANALYSIS: NEAR-INFRARED IMAGING MARKET
・ TABLE 11 IMPORT DATA FOR NEAR-INFRARED IMAGING (HS CODE 902750), BY COUNTRY, 2018–2022 (USD)
・ TABLE 12 EXPORT DATA FOR NEAR-INFRARED IMAGING (HS CODE 902750), BY COUNTRY, 2018–2022 (USD)
5.11 KEY CONFERENCES AND EVENTS (2023–2025)
・ TABLE 13 NEAR-INFRARED IMAGING MARKET: LIST OF KEY CONFERENCES AND EVENTS (2023–2025)
5.12 TECHNOLOGY ANALYSIS
5.13 CASE STUDY ANALYSIS
5.13.1 TECHNOLOGICAL CHALLENGES
・ TABLE 14 CASE STUDY 1: MAINTAINING STRONG FOCUS ON TECHNOLOGICAL INNOVATION AND ADDRESSING REGULATORY COMPLIANCE
5.13.2 LOWERING DEPENDENCE ON CONTRACT MANUFACTURING
・ TABLE 15 CASE STUDY 2: PROVIDING TRAINING AND EDUCATION AND KEEPING UP WITH EVOLVING SURGICAL TECHNIQUES
5.14 PRICING ANALYSIS
・ TABLE 16 REGION-WISE PRICE RANGE FOR NEAR-INFRARED IMAGING SYSTEMS
6 NEAR-INFRARED IMAGING MARKET, BY PRODUCT
6.1 INTRODUCTION
・ TABLE 17 NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
6.2 DEVICES
・ TABLE 18 NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 19 NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 20 NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 21 NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY PROCEDURE, 2021–2028 (USD MILLION)
・ TABLE 22 NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY END USER, 2021–2028 (USD MILLION)
6.2.1 FLUORESCENCE IMAGING SYSTEMS
6.2.1.1 HIGHER SENSITIVITY AND BETTER REAL-TIME IMAGE GUIDANCE DURING SURGERIES TO DRIVE MARKET
・ TABLE 23 FLUORESCENCE IMAGING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.2.2 FLUORESCENCE & BIOLUMINESCENCE IMAGING SYSTEMS
6.2.2.1 BETTER SENSITIVITY AND HIGHER EFFICIENCY AT LOWER COSTS TO DRIVE MARKET
・ TABLE 24 FLUORESCENCE & BIOLUMINESCENCE IMAGING SYSTEMS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3 NIR IMAGING AGENTS/PROBES
・ TABLE 25 NEAR-INFRARED IMAGING MARKET FOR NIR IMAGING AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 26 NEAR-INFRARED IMAGING MARKET FOR NIR IMAGING AGENTS/PROBES, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 27 NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 28 NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY PROCEDURE, 2021–2028 (USD MILLION)
・ TABLE 29 NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY END USER, 2021–2028 (USD MILLION)
6.3.1 INDOCYANINE GREEN 84
6.3.1.1 INCREASING UTILIZATION OF SMALL ORGANIC PROBES IN NEAR-INFRARED IMAGING TO DRIVE SEGMENT
・ TABLE 30 INDOCYANINE GREEN MARKET, BY REGION, 2021–2028 (USD MILLION)
6.3.2 OTHER REAGENTS
6.3.2.1 OTHER REAGENTS TO PROVIDE SPECIFIC FUNCTIONALITIES AND PROPERTIES FOR BETTER IMAGING PROCESS
・ TABLE 31 OTHER REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
6.4 NIR DYES
・ TABLE 32 NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 33 NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY REGION, 2021–2028 (USD MILLION)
・ TABLE 34 NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 35 NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY PROCEDURE, 2021–2028 (USD MILLION)
・ TABLE 36 NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY END USER, 2021–2028 (USD MILLION)
6.4.1 ORGANIC DYES
6.4.1.1 UNIQUE MOLECULAR STRUCTURE AND BETTER COMPATIBILITY WITH BIOLOGICAL SYSTEMS TO DRIVE SEGMENT
・ TABLE 37 ORGANIC DYES MARKET, BY REGION, 2021–2028 (USD MILLION)
6.4.2 NANOPARTICLE DYES 89
6.4.2.1 BETTER BRIGHTNESS AND ENHANCED SIGNAL INTENSITY COMPARED TO ORGANIC DYES TO DRIVE SEGMENT
・ TABLE 38 NANOPARTICLE DYES MARKET, BY REGION, 2021–2028 (USD MILLION)
7 NEAR-INFRARED IMAGING MARKET, BY PROCEDURE
7.1 INTRODUCTION
・ TABLE 39 NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
7.2 CANCER SURGERIES
・ TABLE 40 NEAR-INFRARED IMAGING MARKET FOR CANCER SURGERIES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 41 NEAR-INFRARED IMAGING MARKET FOR CANCER SURGERIES, BY REGION, 2021–2028 (USD MILLION)
7.2.1 BRAIN CANCER/TUMOR SURGERIES
7.2.1.1 ADVANCEMENTS IN SURGICAL NAVIGATION USING NIR-I/II FLUORESCENCE IMAGING TO DRIVE MARKET
・ TABLE 42 BRAIN CANCER/TUMOR SURGERIES MARKET, BY REGION, 2021–2028 (USD MILLION)
7.2.2 OTHER CANCER SURGERIES
7.2.2.1 BETTER TISSUE PENETRATION AND LOWER AUTOFLUORESCENCE LEVELS TO DRIVE MARKET
・ TABLE 43 OTHER CANCER SURGERIES MARKET, BY REGION, 2021–2028 (USD MILLION)
7.3 GASTROINTESTINAL SURGERIES
・ TABLE 44 NEAR-INFRARED IMAGING MARKET FOR GASTROINTESTINAL SURGERIES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 45 NEAR-INFRARED IMAGING MARKET FOR GASTROINTESTINAL SURGERIES, BY REGION, 2021–2028 (USD MILLION)
7.3.1 COLORECTAL SURGERIES
7.3.1.1 ADVANCEMENTS IN TREATMENT STRATEGIES AND PROCEDURES TO DRIVE MARKET 97
・ TABLE 46 COLORECTAL SURGERIES MARKET, BY REGION, 2021–2028 (USD MILLION)
7.3.2 OTHER GASTROINTESTINAL SURGERIES
7.3.2.1 PRECISE VISUALIZATION OF NEAR-INFRARED IMAGING TO DRIVE MARKET 98
・ TABLE 47 OTHER GASTROINTESTINAL SURGERIES MARKET, BY REGION, 2021–2028 (USD MILLION)
7.4 CARDIOVASCULAR DISEASES
7.4.1 RISING PREVALENCE OF CARDIOVASCULAR DISEASES AMONG ALL AGE GROUPS TO DRIVE MARKET
・ TABLE 48 NEAR-INFRARED IMAGING MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2021–2028 (USD MILLION)
7.5 PLASTIC/RECONSTRUCTIVE SURGERIES
7.5.1 RISING NUMBER OF RECONSTRUCTIVE SURGERIES GLOBALLY TO DRIVE MARKET
・ TABLE 49 NEAR-INFRARED IMAGING MARKET FOR PLASTIC/RECONSTRUCTIVE SURGERIES, BY REGION, 2021–2028 (USD MILLION)
7.6 OBSTETRICS & GYNECOLOGY SURGERIES
7.6.1 INCREASED NUMBER OF CLINICAL TRIALS AND IMPROVED TISSUE CONTRAST DURING SURGERIES TO DRIVE MARKET
・ TABLE 50 NEAR-INFRARED IMAGING MARKET FOR OBSTETRICS & GYNECOLOGY SURGERIES, BY REGION, 2021–2028 (USD MILLION) 102
7.7 OTHER PROCEDURES
・ TABLE 51 NEAR-INFRARED IMAGING MARKET FOR OTHER PROCEDURES, BY REGION, 2021–2028 (USD MILLION)
8 NEAR-INFRARED IMAGING MARKET, BY APPLICATION
8.1 INTRODUCTION
・ TABLE 52 NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
8.2 PRECLINICAL IMAGING
8.2.1 GROWING FOCUS ON DEVELOPING NEW TREATMENTS FOR CHRONIC DISEASES TO DRIVE MARKET
・ TABLE 53 NEAR-INFRARED IMAGING MARKET FOR PRECLINICAL IMAGING, BY REGION, 2021–2028 (USD MILLION)
8.3 CLINICAL IMAGING
8.3.1 INCREASING USE OF NEAR-INFRARED IMAGING FOR REAL-TIME VISUALIZATION DURING SURGERIES TO DRIVE MARKET
・ TABLE 54 NEAR-INFRARED IMAGING MARKET FOR CLINICAL IMAGING, BY REGION, 2021–2028 (USD MILLION)
8.4 MEDICAL IMAGING
8.4.1 APPLICATIONS OF FLUORESCENCE IMAGING SINGLE-CELL TRACKING FOR STUDYING IMMUNE SYSTEM TO DRIVE MARKET
・ TABLE 55 NEAR-INFRARED IMAGING MARKET FOR MEDICAL IMAGING, BY REGION, 2021–2028 (USD MILLION)
9 NEAR-INFRARED IMAGING MARKET, BY END USER
9.1 INTRODUCTION
・ TABLE 56 NEAR-INFRARED IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2 HOSPITALS & SURGICAL CLINICS
9.2.1 RISING NUMBER OF CANCER AND RECONSTRUCTIVE SURGERIES TO DRIVE MARKET
・ TABLE 57 NEAR-INFRARED IMAGING MARKET FOR HOSPITALS & SURGICAL CLINICS, BY REGION, 2021–2028 (USD MILLION)
9.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
9.3.1 GROWING PRECLINICAL RESEARCH AND DRUG DISCOVERY TO DRIVE MARKET
・ TABLE 58 NEAR-INFRARED IMAGING MARKET FOR PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2021–2028 (USD MILLION)
9.4 RESEARCH LABORATORIES & ACADEMIC INSTITUTES
9.4.1 FUNDING FROM GOVERNMENT ORGANIZATIONS FOR BIOMEDICAL RESEARCH TO DRIVE MARKET
・ TABLE 59 NEAR-INFRARED IMAGING MARKET FOR RESEARCH LABORATORIES & ACADEMIC INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
9.5 OTHER END USERS
・ TABLE 60 NEAR-INFRARED IMAGING MARKET FOR OTHER END USERS, BY REGION, 2021–2028 (USD MILLION)
10 NEAR-INFRARED IMAGING MARKET, BY REGION
10.1 INTRODUCTION
・ TABLE 61 NEAR-INFRARED IMAGING MARKET, BY REGION, 2021–2028 (USD MILLION)
10.2 NORTH AMERICA
・ FIGURE 26 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET SNAPSHOT
・ TABLE 62 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 63 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 64 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 65 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 66 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 67 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 68 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
・ TABLE 69 NORTH AMERICA: NEAR-INFRARED IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.2.1 US
10.2.1.1 ADVANCED HEALTHCARE INFRASTRUCTURE AND FAVORABLE REGULATIONS TO DRIVE MARKET
・ TABLE 70 US: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 71 US: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 72 US: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 73 US: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
10.2.2 CANADA
10.2.2.1 INCREASED AVAILABILITY OF RESEARCH FUNDING TO DRIVE MARKET
・ TABLE 74 CANADA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 75 CANADA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 76 CANADA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 77 CANADA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
10.3 EUROPE
・ TABLE 78 EUROPE: NEAR-INFRARED IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 79 EUROPE: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 80 EUROPE: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 81 EUROPE: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 82 EUROPE: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 83 EUROPE: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 84 EUROPE: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
・ TABLE 85 EUROPE: NEAR-INFRARED IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.3.1 GERMANY
10.3.1.1 INCREASING HEALTHCARE EXPENDITURE AND GOVERNMENT SPENDING TO DRIVE MARKET
・ TABLE 86 GERMANY: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 87 GERMANY: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 88 GERMANY: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 89 GERMANY: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
10.3.2 FRANCE
10.3.2.1 INCREASING TARGET PATIENT POPULATION AND RISING NUMBER OF DIAGNOSTIC TESTS FOR CHRONIC DISEASES TO DRIVE MARKET
・ TABLE 90 FRANCE: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 91 FRANCE: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 92 FRANCE: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 93 FRANCE: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
10.3.3 UK
10.3.3.1 GROWING GOVERNMENT INITIATIVES AND INCREASING INCIDENCES OF CHRONIC DISEASES TO DRIVE MARKET
・ TABLE 94 UK: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 95 UK: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 96 UK: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 97 UK: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
10.3.4 ITALY
10.3.4.1 INCREASED AVAILABILITY OF REIMBURSEMENT COVERAGE FOR DIAGNOSTIC PROCEDURES TO DRIVE MARKET
・ TABLE 98 ITALY: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 99 ITALY: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 100 ITALY: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 101 ITALY: NEAR-INFRARED IMAGING MARKET FOR NIR DYE, BY TYPE, 2021–2028 (USD MILLION)
10.3.5 SPAIN
10.3.5.1 INCREASING PREVALENCE OF CANCER AND GROWING PRIVATE-PUBLIC FUNDING TO DRIVE MARKET
・ TABLE 102 SPAIN: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 103 SPAIN: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 104 SPAIN: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 105 SPAIN: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
10.3.6 REST OF EUROPE
・ TABLE 106 REST OF EUROPE: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 107 REST OF EUROPE: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 108 REST OF EUROPE: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 109 REST OF EUROPE: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
10.4 ASIA PACIFIC
・ FIGURE 27 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET SNAPSHOT
・ TABLE 110 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 111 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 112 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 113 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 114 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 115 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 116 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
・ TABLE 117 ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.4.1 CHINA
10.4.1.1 INCREASING HEALTHCARE REFORMS AND GOVERNMENT INVESTMENTS TO DRIVE MARKET
・ TABLE 118 CHINA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 119 CHINA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 120 CHINA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 121 CHINA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
10.4.2 JAPAN
10.4.2.1 FAST ADOPTION OF ADVANCED TECHNOLOGIES AND GROWTH IN GERIATRIC POPULATION TO DRIVE MARKET
・ TABLE 122 JAPAN: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 123 JAPAN: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 124 JAPAN: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 125 JAPAN: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
10.4.3 INDIA
10.4.3.1 INCREASING NUMBER OF DIAGNOSTIC PROCEDURES AND IMPROVING HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET
・ TABLE 126 INDIA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 127 INDIA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 128 INDIA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 129 INDIA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
10.4.4 AUSTRALIA
10.4.4.1 GROWING HEALTHCARE SPENDING AND INCREASING INVESTMENTS IN RESEARCH TO DRIVE MARKET
・ TABLE 130 AUSTRALIA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 131 AUSTRALIA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 132 AUSTRALIA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 133 AUSTRALIA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
10.4.5 SOUTH KOREA
10.4.5.1 PRESENCE OF ADVANCED HEALTHCARE SYSTEM AND INCREASED AWARENESS ABOUT DISEASES TO DRIVE MARKET
・ TABLE 134 SOUTH KOREA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 135 SOUTH KOREA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 136 SOUTH KOREA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 137 SOUTH KOREA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
10.4.6 REST OF ASIA PACIFIC
・ TABLE 138 REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 139 REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 140 REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 156
・ TABLE 141 REST OF ASIA PACIFIC: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
10.5 LATIN AMERICA
・ TABLE 142 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
・ TABLE 143 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 144 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 145 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 146 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 147 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 148 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
・ TABLE 149 LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
10.5.1 BRAZIL
10.5.1.1 GREATER PURCHASING POWER AND MORE FAVORABLE DEMOGRAPHIC CONDITIONS TO DRIVE MARKET
・ TABLE 150 BRAZIL: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 151 BRAZIL: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 152 BRAZIL: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 153 BRAZIL: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
10.5.2 MEXICO
10.5.2.1 INCREASED MEDICAL TOURISM AND BETTER GOVERNMENT HEALTHCARE INITIATIVES TO DRIVE MARKET
・ TABLE 154 MEXICO: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 155 MEXICO: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 156 MEXICO: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 157 MEXICO: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
10.5.3 REST OF LATIN AMERICA
・ TABLE 158 REST OF LATIN AMERICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 159 REST OF LATIN AMERICA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 160 REST OF LATIN AMERICA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION) 165
・ TABLE 161 REST OF LATIN AMERICA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 GROWING MEDICAL TOURISM TO DRIVE MARKET
・ TABLE 162 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY PRODUCT, 2021–2028 (USD MILLION)
・ TABLE 163 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET FOR DEVICES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 164 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET FOR NIR AGENTS/PROBES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 165 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET FOR NIR DYES, BY TYPE, 2021–2028 (USD MILLION)
・ TABLE 166 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
・ TABLE 167 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY PROCEDURE, 2021–2028 (USD MILLION)
・ TABLE 168 MIDDLE EAST & AFRICA: NEAR-INFRARED IMAGING MARKET, BY END USER, 2021–2028 (USD MILLION)
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 STRATEGIES ADOPTED BY KEY PLAYERS
11.2.1 OVERVIEW OF KEY STRATEGIES ADOPTED BY PLAYERS IN NEAR-INFRARED IMAGING MARKET
11.3 REVENUE SHARE ANALYSIS
・ FIGURE 28 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN NEAR-INFRARED IMAGING MARKET, 2022
11.4 MARKET SHARE ANALYSIS
・ FIGURE 29 MARKET SHARE ANALYSIS OF TOP PLAYERS IN NEAR-INFRARED IMAGING MARKET, 2022
・ TABLE 169 NEAR-INFRARED IMAGING MARKET: DEGREE OF COMPETITION
11.5 COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
11.5.1 STARS
11.5.2 EMERGING LEADERS 172
11.5.3 PERVASIVE PLAYERS 172
11.5.4 PARTICIPANTS
・ FIGURE 30 NEAR-INFRARED IMAGING MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
11.6 COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022)
11.6.1 PROGRESSIVE COMPANIES
11.6.2 STARTING BLOCKS 174
11.6.3 RESPONSIVE COMPANIES
11.6.4 DYNAMIC COMPANIES 174
・ FIGURE 31 NEAR-INFRARED IMAGING MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
11.7 COMPETITIVE BENCHMARKING
・ TABLE 170 PRODUCT AND GEOGRAPHICAL FOOTPRINT ANALYSIS OF KEY PLAYERS
・ TABLE 171 PRODUCT FOOTPRINT OF COMPANIES
・ TABLE 172 GEOGRAPHICAL FOOTPRINT OF COMPANIES
11.8 COMPETITIVE SCENARIOS AND TRENDS
・ TABLE 173 KEY PRODUCT LAUNCHES
・ TABLE 174 KEY DEALS
・ TABLE 175 OTHER KEY DEVELOPMENTS
12 COMPANY PROFILES
(BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS & MNM VIEW)*
12.1 KEY PLAYERS 180
12.1.1 STRYKER
・ TABLE 176 STRYKER: COMPANY OVERVIEW
・ FIGURE 32 STRYKER: COMPANY SNAPSHOT (2022)
12.1.2 KARL STORZ SE & CO. KG
・ TABLE 177 KARL STORZ SE & CO. KG: COMPANY OVERVIEW
12.1.3 CARL ZEISS MEDITEC AG
・ TABLE 178 CARL ZEISS MEDITEC GROUP: COMPANY OVERVIEW
・ FIGURE 33 CARL ZEISS MEDITEC GROUP: COMPANY SNAPSHOT (2022)
12.1.4 LEICA MICROSYSTEMS
・ TABLE 179 LEICA MICROSYSTEMS: COMPANY OVERVIEW
・ FIGURE 34 LEICA MICROSYSTEMS (DANAHER CORPORATION): COMPANY SNAPSHOT (2022)
12.1.5 OLYMPUS CORPORATION
・ TABLE 180 OLYMPUS CORPORATION: COMPANY OVERVIEW
・ FIGURE 35 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022)
12.1.6 SHIMADZU CORPORATION
・ TABLE 181 SHIMADZU CORPORATION: COMPANY OVERVIEW
・ FIGURE 36 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2021)
12.1.7 PERKINELMER, INC. 199
・ TABLE 182 PERKINELMER, INC.: COMPANY OVERVIEW
・ FIGURE 37 PERKINELMER, INC.: COMPANY SNAPSHOT (2021)
12.1.8 LI-COR, INC.
・ TABLE 183 LI-COR, INC.: COMPANY OVERVIEW
12.1.9 HAMAMATSU PHOTONICS K.K.
・ TABLE 184 HAMAMATSU PHOTONICS K.K.: COMPANY OVERVIEW
・ FIGURE 38 HAMAMATSU PHOTONICS K.K.: COMPANY SNAPSHOT (2022)
12.1.10 QUEST MEDICAL IMAGING B.V. 207
・ TABLE 185 QUEST MEDICAL IMAGING B.V.: COMPANY OVERVIEW
12.1.11 SIGMA-ALDRICH (MERCK)
・ TABLE 186 SIGMA-ALDRICH: COMPANY OVERVIEW
・ FIGURE 39 SIGMA-ALDRICH: COMPANY SNAPSHOT (2022)
12.1.12 MIZUHO MEDICAL CO., LTD.
・ TABLE 187 MIZUHO MEDICAL CO., LTD.: COMPANY OVERVIEW
12.1.13 TELEDYNE PRINCETON INSTRUMENTS
・ TABLE 188 TELEDYNE PRINCETON INSTRUMENTS: COMPANY OVERVIEW
・ FIGURE 40 TELEDYNE PRINCETON INSTRUMENTS: COMPANY SNAPSHOT (2022)
12.1.14 THERMO FISHER SCIENTIFIC INC.
・ TABLE 189 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
・ FIGURE 41 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
12.1.15 FLUOPTICS
・ TABLE 190 FLUOPTICS: COMPANY OVERVIEW 216
12.1.16 MEDTRONIC
・ TABLE 191 MEDTRONIC: COMPANY OVERVIEW 217
12.1.17 CAYMAN CHEMICAL
・ TABLE 192 CAYMAN CHEMICAL: COMPANY OVERVIEW
12.1.18 MP BIOMEDICALS
・ TABLE 193 MP BIOMEDICALS: COMPANY OVERVIEW
12.1.19 CRYSTA-LYN CHEMICAL COMPANY 220
・ TABLE 194 CRYSTA-LYN CHEMICAL COMPANY: COMPANY OVERVIEW
12.1.20 GOWERLABS LTD.
・ TABLE 195 GOWERLABS LTD.: COMPANY OVERVIEW
*DETAILS ON BUSINESS OVERVIEW, PRODUCTS OFFERED, RECENT DEVELOPMENTS & MNM VIEW MIGHT NOT BE CAPTURED IN CASE OF UNLISTED COMPANIES.
12.2 OTHER COMPANIES
12.2.1 NIRX MEDICAL TECHNOLOGIES, LLC
12.2.2 XENICS NV
12.2.3 BIOTIUM
12.2.4 TOKYO CHEMICAL INDUSTRY (INDIA) PVT. LTD.
12.2.5 AAT BIOQUEST, INC.